Serotonin transporter genomic biomarker for quantitative assessment of ondansetron treatment response in alcoholics.

Front Psychiatry · 2012 · PMC3314249 · PMID 22470354

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As illustrated in Figure 1 , subjects carrying the LL genotype who were treated with ondansetron showed a trend toward having decreased serotonin transporter mRNA expression levels with decreasing drinking levels (slope = +1.1698) during the 11-week treatment period.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.